<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The long-term effects of the <z:chebi fb="0" ids="28790">5-HT</z:chebi>(2A) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> <z:chebi fb="0" ids="6123">ketanserin</z:chebi> on deficits in sensorimotor integration (limb placing tests) following transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats were compared to the effects of the <z:chebi fb="0" ids="31882">NMDA</z:chebi> <z:chebi fb="68" ids="48706">antagonist</z:chebi> MK-801 </plain></SENT>
<SENT sid="1" pm="."><plain>Middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> was induced in conscious rats by microinjection of endothelin-1 in the vicinity of the artery (EMCAO model) </plain></SENT>
<SENT sid="2" pm="."><plain>The EMCAO/vehicle rats exhibited impaired tactile and proprioceptive limb placing </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast to <z:chebi fb="0" ids="6123">ketanserin</z:chebi>, MK-801 exerted severe early <z:hpo ids='HP_0000708'>behavioral disturbances</z:hpo>, but both drugs significantly improved the neurological scores much earlier than the spontaneous recovery of function occurred </plain></SENT>
<SENT sid="4" pm="."><plain>The present results suggest that pharmacotherapy by means of <z:chebi fb="0" ids="6123">ketanserin</z:chebi> lacking the severe side effects of the <z:chebi fb="0" ids="31882">NMDA</z:chebi> <z:chebi fb="68" ids="48706">antagonists</z:chebi> can be used to enhance functional recovery after <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>